This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Amblyopia Treatment Market

Advancements in Eye Care opening up renewed growth frontiers for Amblyopia Treatment in the coming decade

Amblyopia Treatment Market By Treatment Type, Distribution Channel & Region- Forecast 2022 – 2032

Amblyopia Treatment Market Snapshot (2022-2032)

[302 Pages Report] The global amblyopia treatment market is anticipated to be valued at US$ 3,724.2Million in 2022, forecast to grow at a CAGR of 3.8% to be valued at US$ 5,604.2Million from 2022 to 2032. Growth is attributed to the increasing ophthalmological disorders like cataracts and refractive errors. From 2016-2021 a CAGR of 3.1% was registered for the lactic acid market.

Data Points

Key Statistics

Expected Base Year Value (2021)

US$ 3,587.8 Million

Growth Rate (2016-2021)

3.1% CAGR

Projected Growth Rate (2022-2032)

3.8% CAGR

Expected Market Value (2022)

US$ 3,724.2 Million

Anticipated Forecast Value (2032)

US$ 5,604.2 Million

Amblyopia, often called lazy eye or lazy vision is a serious eye condition that affects vision. Poor sight develops in one eye during infancy or childhood and gets worse over time if not treated. Early screening is important because treatment is more effective when started early. Treatments include an eye patch or glasses.

Amblyopia occurs when there is a major difference between the two eyes in their ability to focus. The most common cause of amblyopia is other vision problems. It’s important to treat these other conditions, or the brain starts relying on the eye for better vision, leading to amblyopia.

Atropine sulfate eye drops are being used for treating different eye disorders including amblyopia and cycloplegia. Players in the global amblyopia treatment market are increasing research activities that are focused on preventing potential side-effects of these drops such as difficulty in seeing at night, eye pain, and blurred vision.

North America is considered to be a highly lucrative market for the amblyopia treatment market, driven primarily by the presence of a large number of players in the region. Simultaneously, the lack of resources in developing countries is acting as a significant growth barrier.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are Some Prominent Drivers Spearheading Amblyopia Treatment Market Growth?

The growing prevalence of hypermetropia and myopia across the globe is expected to play a key role in driving the market during the forecast period. Players are adopting various innovative methods to advance the treatment method which is projected to offer remunerative opportunities to the industry in the forthcoming time.

Many healthcare experts are enhancing the application of video games as one of the methods to treat amblyopia Players in the market are focused on increasing awareness through video games as a treatment during the early age in children so that their brains can work with the weaker eye by developing better connections between the eye and brain Such initiatives are expected to propel the market growth in the coming period.

Other factors like increasing demand for eye patches and glasses, computer-based vision therapy, and electronic eyeglasses and lenses that correct for aniseikonia are expected to develop the market in the coming time. Increasing focus on technological development for advanced products in amblyopia treatment is likely to offer significant opportunities to the market in the forthcoming period.

Major players focus on launch of technologically advanced products for treatment of amblyopia. This is anticipated to augment the global amblyopia treatment market during the forecast period. In March 2021, NovaSight received the Food and Drug Administration 510(k) clearance for CureSight for the treatment of amblyopia. The device trains the brain to use both eyes simultaneously, while the user watches videos through 3D glasses.

What are the Challenges Faced by the Amblyopia Treatment Industry?

Lack of awareness regarding the disorder is expected to hamper the market in the forecast period. Also, the lack of resources in developing countries is anticipated to be another factor limiting the market expansion in the forthcoming period.

However, developing healthcare infrastructure and the growing investment of government in evolving economies are expected to act as a significant counter to the hampering causes and propel market growth in the coming time.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Emerging as an Opportunistic Amblyopia Treatment Market?

As per the analysis, North America is anticipated to dominate the market during the forecast period. In 2022, the region is expected to secure about 38.6% of the global market share. The U.S is projected to make the maximum contribution to developing the market in the coming period.

Domination of the region can be attributed to the presence of major players in the region. Also, the integration of advanced technology to offer better treatment is projected to be another key factor strengthening the regional market in the forecast period. The growth in North America is attributed to factor such as early acceptance of new products, sturdy healthcare infrastructure, existence of many key players, and increased cases of amblyopia in the region

Additionally, increasing clearances by FDA to players is expected to augment the market size in the forecast period. In October 2021, Luminopia, a digital therapeutics company, announced that the U.S FDA has granted de novo premarket approval for Luminopia One as a prescription therapy to enhance vision in children with amblyopia, major cause of vision loss in children. Owing to such factors, the market in the region is expected to flourish during the forecast period.

What Is the Contribution of Europe in the Global Amblyopia Treatment Market?

As per the analysis, the European amblyopia treatment market is projected to witness significant growth opportunities in the forecast period. As of 2022, the region is expected to procure about 30.5% of the global market share. The U.K is predicted to make the most significant contribution to developing the regional market. This can be attributed to the presence of resources, the contribution of major players, and the ongoing development of the treatment.

Furthermore, acquisitions among players are projected to widen the market size during the forecast period. For instance, in April 2020, Novartis acquired Amblyotech, a US-based software startup, and in collaboration with Ubisoft and McGill University, will pursue the development of acquired digital technology for the treatment of amblyopia. Such factors are expected to boost the European market in the forecast period.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Will the Asia Pacific emerge as an Attractive Amblyopia Treatment Market?

The Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the amblyopia treatment market in the region.

Asia-Pacific is expected to grow in the over coming years due to increased new research and developments in the amblyopia treatment market and increasing healthcare expenditure contributes in raising the significant growth of the market. The shift of the people towards health awareness and improvement in healthcare facilities has contributed towards the growth of the market in this region.

Start-up Scenario

Eye Bab, CureSee, Novartis, Amblyotech, Bynocs, Asg eye hospital, are some of the start-ups in the amblyopia treatment market.

  • In November 2020- EYEBAB entered into a distribution agreement with the American company Vivid Vision. The new agreement means that EYEBAB’s recognized vision training platform will now be available in the US and Canadian distribution and will be made available to Vivid Vision’s large professional network worldwide.

Market Competition

Some of the key participants present in the global amblyopia treatment market are Vivid Vision, 3M, Lancastle International Ltd, Johnson and Johnson, Trayner, Good-Lite, HOYA Vision Care Company, Ortopad USA, NovaSight, and Revital Vision among others.

Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Vivid Vision, 3M, Lancastle International Ltd account for considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.

  • In November 2020- RevitalVision announces the release of new web vision training software application with RevitalVision new branding. This advance software, which is designed to improve vision by improving the brain visual processing, is easier to use and provides better patient feedback.
  • In October 2021 HOYA Vision Care, announced a partnership with Orbis International, a global organization that mentors, trains, and inspires local eye care professionals to save sight in their communities. This strategic partnership marks a significant step in HOYA’s Corporate Social Responsibility (CSR) program, which is aimed at bridging the vision care gap around the world.

Report Scope

Report Attribute

Details

Growth Rate

3.1% CAGR from 2022 to 2032

Market Value in 2022

US$ 3,724.2 Million

Market Value in 2032

US$ 5,604.2 Million

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

USD Million for Value

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Treatment Type
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • Italy
  • France
  • Russia
  • U.K
  • BENELUX
  • China
  • Japan
  • South Korea
  • GCC
  • South Africa
  • Turkey

Key Companies Profiled

  • Vivid Vision
  • 3M
  • Lancastle International Ltd
  • Johnson and Johnson
  • Trayner
  • Good-Lite
  • HOYA Vision Care Company
  • Ortopad USA
  • NovaSight
  • Revital Vision

Customization Scope

Available upon Request

Key Segments Profiled In The Global Amblyopia Treatment Market

Global Amblyopia Treatment Market by Treatment Type:

  • Amblyopia Treatment by Eye Patches
  • Amblyopia Treatment by Spectacle Lenses
  • Amblyopia Treatment by Eye Drops & Ointments
  • Amblyopia Treatment by Surgery
  • Other Amblyopia Treatment Types

Amblyopia Treatment Market by Distribution Channel:

  • Amblyopia Treatment Drug Sales via Pharmacies
  • Amblyopia Treatment Drug Sales via Drug Stores
  • Amblyopia Treatment Drug Sales via Hypermarkets and Supermarkets
  • Amblyopia Treatment Drug Sales via E-Commerce

Amblyopia Treatment Market by Region:

  • North American Amblyopia Treatment
  • Latin American Amblyopia Treatment
  • Europe Amblyopia Treatment
  • Asia Pacific Amblyopia Treatment
  • Middle East & African Amblyopia Treatment

Frequently Asked Questions

FMI projects the global amblyopia treatment market to expand at a 3.8% value CAGR by 2032

North America is expected to be the most opportunistic with a 38.6% share of the total amblyopia treatment market

Vivid Vision, 3M, Lancastle International Ltd are some prominent amblyopia treatment market players.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Treatment Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Treatment Type, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment Type, 2022-2032

        5.3.1. Eye Patches

        5.3.2. Spectacle Lenses

        5.3.3. Eye Drops & Ointments

        5.3.4. Surgery

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Treatment Type, 2022-2032

6. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Distribution Channel

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        6.3.1. Pharmacies

        6.3.2. Drug Store

        6.3.3. Hypermarkets and Supermarkets

        6.3.4. E-Commerce

    6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2016-2021

    6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032

7. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Treatment Type

        8.2.3. By Distribution Channel

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Treatment Type

        8.3.3. By Distribution Channel

    8.4. Key Takeaways

9. Latin America Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Treatment Type

        9.2.3. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Treatment Type

        9.3.3. By Distribution Channel

    9.4. Key Takeaways

10. Europe Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Russia

            10.2.1.6. BENELUX

            10.2.1.7. Rest of Europe

        10.2.2. By Treatment Type

        10.2.3. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Treatment Type

        10.3.3. By Distribution Channel

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Treatment Type

        11.2.3. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Treatment Type

        11.3.3. By Distribution Channel

    11.4. Key Takeaways

12. Middle East and Africa Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Turkey

            12.2.1.4. Rest of Middle East and Africa

        12.2.2. By Treatment Type

        12.2.3. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Treatment Type

        12.3.3. By Distribution Channel

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Treatment Type

            13.1.2.2. By Distribution Channel

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Treatment Type

            13.2.2.2. By Distribution Channel

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Treatment Type

            13.3.2.2. By Distribution Channel

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Treatment Type

            13.4.2.2. By Distribution Channel

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Treatment Type

            13.5.2.2. By Distribution Channel

    13.6. Italy

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Treatment Type

            13.6.2.2. By Distribution Channel

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Treatment Type

            13.7.2.2. By Distribution Channel

    13.8. U.K.

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Treatment Type

            13.8.2.2. By Distribution Channel

    13.9. Russia

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Treatment Type

            13.9.2.2. By Distribution Channel

    13.10. BENELUX

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Treatment Type

            13.10.2.2. By Distribution Channel

    13.11. China

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Treatment Type

            13.11.2.2. By Distribution Channel

    13.12. Japan

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Treatment Type

            13.12.2.2. By Distribution Channel

    13.13. South Korea

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Treatment Type

            13.13.2.2. By Distribution Channel

    13.14. GCC Countries

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Treatment Type

            13.14.2.2. By Distribution Channel

    13.15. South Africa

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Treatment Type

            13.15.2.2. By Distribution Channel

    13.16. Turkey

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Treatment Type

            13.16.2.2. By Distribution Channel

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Treatment Type

        14.3.3. By Distribution Channel

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Vivid Vision

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. 3M

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Lancastle International Ltd

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Johnson and Johnson

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Trayner

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Good-Lite

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. HOYA Vision Care Company

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Ortopad USA

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. NovaSight

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Revital Vision

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 03: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 04: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 05: North America Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 06: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 07: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 08: Latin America Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 09: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 12: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 16: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: Middle East and Africa Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 18: Middle East and Africa Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 02: Global Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 03: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 04: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 05: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 06: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 07: Global Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 08: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 09: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 10: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 13: Global Market Attractiveness by Treatment Type, 2022-2032

Figure 14: Global Market Attractiveness by Distribution Channel, 2022-2032

Figure 15: Global Market Attractiveness by Region, 2022-2032

Figure 16: North America Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 17: North America Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 28: North America Market Attractiveness by Treatment Type, 2022-2032

Figure 29: North America Market Attractiveness by Distribution Channel, 2022-2032

Figure 30: North America Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 32: Latin America Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 40: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 43: Latin America Market Attractiveness by Treatment Type, 2022-2032

Figure 44: Latin America Market Attractiveness by Distribution Channel, 2022-2032

Figure 45: Latin America Market Attractiveness by Country, 2022-2032

Figure 46: Europe Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 47: Europe Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 53: Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 55: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 56: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 58: Europe Market Attractiveness by Treatment Type, 2022-2032

Figure 59: Europe Market Attractiveness by Distribution Channel, 2022-2032

Figure 60: Europe Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 62: Asia Pacific Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 73: Asia Pacific Market Attractiveness by Treatment Type, 2022-2032

Figure 74: Asia Pacific Market Attractiveness by Distribution Channel, 2022-2032

Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 76: Middle East and Africa Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 77: Middle East and Africa Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 78: Middle East and Africa Market Value (US$ Mn) by Country, 2022-2032

Figure 79: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: Middle East and Africa Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 85: Middle East and Africa Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 88: Middle East and Africa Market Attractiveness by Treatment Type, 2022-2032

Figure 89: Middle East and Africa Market Attractiveness by Distribution Channel, 2022-2032

Figure 90: Middle East and Africa Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

New Born Eye Imaging Systems Market

Published : June 2017

Healthcare

Bionic Eye Market

Published : March 2016

Healthcare

Eye Infections Treatment Market

Published : February 2022

Healthcare

Dry Eye Syndrome Treatment Market

Published : February 2022

Google translate

Amblyopia Treatment Market